๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hefei
Clinical trial register · China

Clinical Trials in Hefei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 51 Guangzhou 16 Changchun 10 Shanghai 9 Fuzhou 8
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing51 Guangzhou16 Changchun10 Shanghai9 Fuzhou8
All 121 locations
Target enrolment
to

Trials with a site in Hefei

8 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Real-World Evaluation of Recombinant Human Prourokinase for Acute Ischemic Stroke Within 4.5 Hours
NCT07787325Acute Ischemic Stroke
The First Affiliated Hospital of Anhui Medical University
Observational
3,000
Hefei
2026-09-11
Not yet open
Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
NCT07776873Acute Ischemic Stroke
The First Affiliated Hospital of Anhui Medical University
Phase 3
616
Hefei
2026-09-06
Recruiting
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763Acute Ischemic Stroke
The First Affiliated Hospital of University of Science and Technology of China
Not applicable
406
Hefei
2025-11-05
Not yet open
Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT
NCT07168278Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase, Thrombolysis
The First Affiliated Hospital of University of Science and Technology of China
Phase 3
794
Hefei
2025-11-01
Not yet open
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment
NCT06788626Acute Ischemic Stroke, Large Vessel Occlusion, Neuroprotective Drugs, Endovascular Treatment
Wei Hu
Phase 3
390
Hefei
2025-02
Recruiting
A Multicenter, Randomized Controlled Clinical Investigation to Evaluate the Safety and Effectiveness of the Super-Bore 8/7F Aspiration Catheters in the Treatment of Acute Intracranial Large Vessel Occlusion
NCT06559475Acute Ischemic Stroke, Endovascular Thrombectomy
The First Affiliated Hospital of University of Science and Technology of China
Not applicable
360
Hefei
2024-12-16
Recruiting
Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke
NCT06559436Acute Ischemic Stroke
The First Affiliated Hospital of University of Science and Technology of China
Not applicable
560
Hefei
2024-10-02
Active, closed
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
NCT06360458Acute Ischemic Stroke, Large Infarct Core
Wan-Jin Chen
Phase 3
928
Hefei, Taihe Chengguanzhen, Wuhu, Anxi, Fuqing, Fuzhou, Longyan, Nanping
2024-08-01
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/hefei

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Hefei that also match the filters currently applied.

How many clinical trials are recruiting in Hefei?

3 of the 8 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hefei), 8 studies
PhaseStudiesRecruitingShare
Phase 34050%
Not applicable3337.5%
Observational1012.5%

Most active sponsors

Lead sponsors with the most studies (Hefei)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of University of Science and Technology of China43
The First Affiliated Hospital of Anhui Medical University20
Wan-Jin Chen10
Wei Hu10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.